The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Abstract
Background— Cigarette smoking causes endothelial dysfunction, possibly through increased oxidant stress. The enzyme xanthine oxidase produces oxidative free radicals. We tested the hypothesis that xanthine oxidase contributes to endothelial dysfunction in cigarette smokers by administering the inhibitor allopurinol. Methods and Results— Fourteen cigarette smokers (31±4 pack years) and 14 age- and sex-matched healthy non-smoking control subjects participated in a single-blinded, randomized, 2-phase crossover study. All subjects had no other risk factors for atherosclerosis. Inhibition of xanthine oxidase was achieved by a single oral dose of 600 mg of allopurinol on the day of the study. Stimulated nitric oxide endothelial responses were assessed by forearm blood flow responses to intraarterial administration of acetylcholine and bradykinin 4 to 7 hours later; basal nitric oxide was assessed using the nitric oxide synthase inhibitor NG-monomethyl- l -arginine (L-NMMA); and nitroprusside was used to assess sensitivity to nitric oxide. Dilatation produced by acetylcholine was significantly less in smokers (254±57%) than healthy controls (390±55%) ( P =0.009). Allopurinol reversed endothelial dysfunction in smokers (acetylcholine, 463±78%, P =0.001) without affecting responses in non-smokers (401±80%). Bradykinin responses were also impaired in smokers ( P =0.003), and improved with allopurinol, though not significantly ( P =0.06). Responses to nitroprusside and L-NMMA were not significantly different between smokers and controls and were not altered by allopurinol. Conclusions— Smoking-induced endothelial dysfunction of resistance vessels is rapidly reversed with oral allopurinol. These data suggest that xanthine oxidase contributes importantly to endothelial dysfunction caused by cigarette smoking.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amelioration of endothelial function in smokers was also observed (387).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [387]
Citations
Cites
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033
Celermajer, D. S., Sørensen, K. E., Georgakopoulos, D., Bull, C., Thomas, O., Robinson, J. T. C., & Deanfield, J. E. (1993) · Circulation · doi:10.1161/01.cir.88.5.2149 · Cited by 1,532
Serum Uric Acid and Cardiovascular Mortality
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,516
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R. G., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure
Farquharson, C. A. J., Butler, R., Hill, A., Belch, J. J. F., & Struthers, A. D. (2002) · Circulation · doi:10.1161/01.cir.0000022140.61460.1d · Cited by 504
Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia
Chowienczyk, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92621-l · Cited by 466
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium
Jarasch, E.-D., Gründ, C., Bruder, G., Heid, H., Keenan, T. W., & Franke, W. W. (1981) · Cell · doi:10.1016/0092-8674(81)90232-4 · Cited by 440
Kanani, P. M., Sinkey, C. A., Browning, R. L., Allaman, M. M., Knapp, H. R., & Haynes, W. G. (1999) · Circulation · doi:10.1161/01.cir.100.11.1161 · Cited by 418
Self-citationRao, G. N., Corson, M. A., & Berk, B. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93017-6 · Cited by 391
Calver, A., Collier, J., Moncada, S., & Vallance, P. J. (1992) · PubMed · Cited by 332
Haynes, W. G., Strachan, F. E., & Webb, D. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.357 · Cited by 279
Self-citationCardillo, C., Kilcoyne, C. M., Cannon, R. O., Quyyumi, A. A., & Panza, J. A. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.57 · Cited by 246
Zweier, J. L., Broderick, R., Kuppusamy, P., Thompson-Gorman, S. L., & Lutty, G. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51062-6 · Cited by 244
Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension
Calver, A., Collier, J., Moncada, S., & Vallance, P. J. (1992) · Journal of Hypertension · doi:10.1097/00004872-199209000-00017 · Cited by 240
Uric acid as a cardiovascular risk factor in arterial hypertension
Puig, J., & Ruilope, L. M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917070-00001 · Cited by 150
Nitrosation of Uric Acid by Peroxynitrite
Skinner, K. A., White, C. R., Patel, R. P., Tan, S., Barnes, S., KIRK, M. C., Darley-Usmar, V. M., & Parks, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24491 · Cited by 133
Uric acid as radical scavenger and antioxidant in the heart
Becker, B. F., Reinholz, N., �z�elik, T., Leipert, B., & Gerlach, E. (1989) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00370582 · Cited by 131
Clinical Pharmacokinetics of Allopurinol
Murrell, G. A. C., & Rapeport, G. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611050-00001 · Cited by 131
Smoking, lipoproteins and coronary heart disease risk Data from the Münster Heart Study (PROCAM)
Cullen, P. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1086 · Cited by 126
Functional improvement precedes structural regression of atherosclerosis.
Benzuly, K. H., Padgett, R. C., Kaul, S., Piegors, D. J., Armstrong, M. L., & Heistad, D. D. (1994) · Circulation · doi:10.1161/01.cir.89.4.1810 · Cited by 106
Berman, R. S., & Martin, W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13487.x · Cited by 102
Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.
Anker, S., Leyva, F., Poole-Wilson, P., Kox, W., Stevenson, J., & Coats, A. (1997) · Heart · doi:10.1136/hrt.78.1.39 · Cited by 95
Xanthine oxidase-induced injury to endothelium: role of intracellular iron and hydroxyl radical
Kvietys, P. R., Inauen, W., Bacon, B. R., & Grisham, M. B. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.5.h1640 · Cited by 89
Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia
Poss, W. B., Huecksteadt, T. P., Panus, P. C., Freeman, B. A., & Hoidal, J. R. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.6.l941 · Cited by 79
Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol
Moffatt, R. J. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90194-3 · Cited by 68
Bagi, Z. A., Ungvari, Z. I., & Koller, Á. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101127 · Cited by 64
Dreher, D., Jornot, L., & Junod, A. F. (1995) · Circulation Research · doi:10.1161/01.res.76.3.388 · Cited by 64
Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects
GRAHAM, S., Day, R. O., WONG, H., McLachlan, A. J., Bergendal, L., Miners, J. O., & Birkett, D. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03116.x · Cited by 58
Kinetics of allopurinol after single intravenous and oral doses
Breithaupt, H., & Tittel, M. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606429 · Cited by 57
Schlaich, M. P., John, S., Jacobi, J., Lackner, K. J., & Schmieder, R. E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00412-3 · Cited by 34
Day, R. O., Miners, J. O., Birkett, D., Graham, G., & Whitehead, A. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03402.x · Cited by 34
Shiode, N., Nakayama, K., Morishima, N., Yamagata, T., Matsuura, H., & Kajiyama, G. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90076-9 · Cited by 31
Oxidative stress induced by bloodless limb surgery on humans
Karg, E., Németh, I., Virág, G., Mészáros, T., BODA, D., & Pintér, S. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2130768.x · Cited by 13
Research works printed but not linked: 11
- 10.1161/circ.88.5.8222109 · DOI
- 10.1161/circ.89.4.8149547 · DOI
- 10.1161/circ.100.11.1161 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/hyp.35.3.746 · DOI
- 1982, Eur J Clin Pharmacol, 22, 77
- 10.1161/circ.92.3.357 · DOI
- 1996, Am J Physiol, 270, L941
- 10.1161/res.76.3.388 · DOI
- 1989, Am J Physiol, 257, H1640
- 10.1161/atvb.22.1.28 · DOI
Cited by
Sorted by citations
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
The pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D. R., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,309
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Metadata
- Authors
- Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G.
- Affiliations
- University of Iowa (US)
- ORCID
- Haynes, William G.
- Venue
- Circulation
- Published
- 2003-01-28
- Volume
- 107
- Issue
- 3
- Pages
- 416-421
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2033870657
- Cited by
- 225
- References
- 35
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 15 · 2020: 3 · 2019: 11 · 2018: 14 · 2017: 11 · 2016: 8 · 2015: 9 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-55006, P50HL055006, HL58972, R01HL058972)
- National Institute of Neurological Disorders and Stroke (NS55105)
- National Center for Research Resources (RR 00059, M01RR000059)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- xanthine oxidase, allopurinol, endothelial dysfunction, cigarette smoking, nitric oxide, acetylcholine-induced vasodilation, bradykinin, forearm blood flow, oxidative stress, resistance vessels, smokers
- MeSH terms
- Adolescent, Adult, Aged, Allopurinol, Endothelium, Vascular, Enzyme Inhibitors, Female, Forearm, Humans, Male, Middle Aged, Regional Blood Flow, Smoking, Vasodilation, Xanthine Oxidase, Single-Blind Method, Cross-Over Studies, Nitric Oxide Synthase, omega-N-Methylarginine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review